ANDA 62653, held by Warner Chilcott. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62653 (Doryx), held by Warner Chilcott, was first approved by FDA on Oct 30, 1985, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 30, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| DoryxEQ 100MG BASE ยท capsule, delayed release;oral | Doxycycline Hyclate | Discontinued |
| Mar 26, 2004 | Supplement 9Labeling | Approved | None posted |
| Nov 10, 2003 | Supplement 8Labeling | Approved | None posted |
| May 11, 2000 | Supplement 5Manufacturing | Approved | None posted |
| Mar 23, 2000 | Supplement 4Manufacturing | Approved | None posted |
| Feb 6, 1998 | Supplement 3Manufacturing | Approved | None posted |
| Jul 31, 1997 | Supplement 2Manufacturing | Approved | None posted |
| Oct 30, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters